August 17, 2020
First Procedures Performed With Transit Scientific’s XO Cross Microcatheter Platform
August 17, 2020—Transit Scientific announced the completion of the first clinical cases using the company’s XO Cross microcatheter platform. Transit Scientific is currently commercializing the 2-F XO Cross 14 microcatheter, the 2.6-F XO Cross 18 microcatheter, and the 3.9-F XO Cross 35 support catheter for use with standard 0.014-, 0.018-, and 0.035-inch guidewires in 90-, 135-, 150-, and 175-cm working lengths.
James McGuckin, MD, of the Lehigh Valley Vascular Institute in Bethlehem, Pennsylvania, performed the procedures using the XO Cross 14 microcatheter, which is designed to facilitate guidewire support, guidewire exchange, and contrast media injection during complex peripheral vascular interventions.
According to the company, the nontapered, metal-alloy and polymer construction of the XO Cross microcatheter provides high fatigue resistance against tough calcium and plaque found in late-stage peripheral artery disease (PAD) and critical limb ischemia (CLI). The device’s pushability, trackability, flexibility, and torque response allow for access to challenging lesions and complex anatomy.
“The 1:1 torque of the XO Cross provided new levels of control and responsiveness during the procedure,” commented Dr. McGuckin in the company’s press release. “The ultra-large lumen and shapeable distal tip allowed for better imaging at the target site as well as directional control for accessing branch anatomy with the wire.”
Dr. McGuckin added, “The XO Cross took a beating during the case and held its own. It has excellent fatigue resistance, which is needed in PAD and CLI cases.”